FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL

FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL

Abstract The FIRE study investigated the real-world effectiveness and safety of ibrutinib in prospectively observed patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL) in France. Patients were mostly relapsed/refractory with high-risk feat...

Full description

Bibliographic Details
Main Authors: Caroline Dartigeas, Borhane Slama, Margaret Doyle, Christoph Tapprich, Claire Albrecht, Sandrine Dupuis, Robert Wapenaar, Charlotte Schmidt-Hieber, Veronique Leblond
Format: Article
Language:English
Published: SAABRON PRESS 2022-09-01
Series:Clinical Hematology International
Subjects:
Ibrutinib
Chronic lymphocytic leukemia
Mantle cell lymphoma
Real-world evidence
Effectiveness
Safety
Online Access:https://doi.org/10.1007/s44228-022-00015-5

Internet

https://doi.org/10.1007/s44228-022-00015-5

Similar Items